Back to 
RENAISSANCE TECHNOLOGIES LLC
RENAISSANCE TECHNOLOGIES LLCGSGSK1
Showing 0 of 13 quarters
Position history for RENAISSANCE TECHNOLOGIES LLC's holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Renaissance Technologies held 9,979,321 shares of GSK1 (Glaxosmithkline), worth $434.4M. Renaissance Technologies' 13F filings listed GSK1 from Q3 2019 to Q2 2022, 12 quarterly filings. GSK1 was 0.5% of Renaissance Technologies' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.